Cedar
PrivateLast Round
Series D
Extension
Dec 19, 2022
Est. Valuation
$3.2B
Total Funding Raised
$422M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cedar operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series D Extension round in December 2022.
Cedar is a healthcare technology company that provides a patient financial engagement platform to streamline billing, payments, and coverage for hospitals, health systems, and medical groups.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Patient Engagement, Digital Payments, EHR & EMR
Business Model
B2B2C
Customer Profile
Payment Processing Fee, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cedar Comparables
Compare Cedar with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Millennia | 83% | |
| RevSpring | 83% | |
| Phreesia Inc | 79% |
For institutional investors. Book with your work email.
Cedar Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Dec 19, 2022 | ||||
| Series D | Mar 9, 2021 | ||||
| Series C | Jun 22, 2020 | ||||
| Debt | Jun 22, 2020 | ||||
| Series B | Jun 25, 2018 | ||||
Series A | Jun 12, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cedar Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series D, Series C |
| SV Angel | Series A |
| Section Partners | Series D |
| Founders Fund | Series C, Series B, Series A, Seed |
| Thrive Capital | Series D, Series C, Series B, Series A, Seed |
| Lakestar | Series C, Series B |
| Sound Ventures | Series D, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Added Gastro Health Group as a customer.
- Jun 17, 2026
Monthly visitors increased 64% MoM, reaching 59.3K.
For institutional investors. Book with your work email.
Cedar Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cedar's valuation, stock price, and market status.
Is Cedar a public or private company?
Cedar is a private company.
What is the current stock price of Cedar?
Cedar is a private company, so its shares have no public market price. Caplight tracks Cedar's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cedar worth (valuation)?
Cedar's valuation is estimated at $3.2B based on funding round data.
Can I buy Cedar stock?
Cedar shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cedar's last funding round?
Cedar's most recent funding round was Series D Extension on December 19, 2022.
Who are the main investors in Cedar?
Key investors in Cedar include Andreessen Horowitz, SV Angel, Founders Fund, Thrive Capital, Tiger Global Management.
Will Cedar IPO soon?
No public IPO plans have been announced for Cedar.
How can I track Cedar secondary market activity?
Caplight tracks bids, offers, and trades in Cedar's shares on secondary markets.